Cummings BB, Marshall JL, Tukiainen T, et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med.2017;9(386).
Parvatiyar MS, Marshall JL, Nguyen RT, et al. Sarcospan regulates cardiac isoproterenol response and prevents Duchenne muscular dystrophy-associated cardiomyopathy. J Am Heart Assoc. 2015;23:4(12).
Marshall JL, Oh J, Chou E, et al. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin. Hum Mol Genet. 2015;24(7):2011–2022.
Jamie Marshall, Ph.D.
Jamie Marshall is a research scientist II in the Program in Medical and Population Genetics, working under the direction of Daniel MacArthur. Marshall leads the MacArthur lab’s efforts to develop in vitro models of severe genetic diseases. Her major current focus is the creation of models of human skeletal muscle “in a dish,” starting from either patient tissue or genome-engineered stem cells. Such models are critical to enable the study of new genes underlying muscular dystrophy and to develop high-throughput screening assays for therapeutic discovery.
Before joining the Broad Institute in December 2014, Marshall completed two 18-month-long postdocs — the first in the Rachelle Crosbie-Watson lab at the University of California at Los Angeles (UCLA) studying the mechanisms of sarcospan-mediated amelioration of muscular dystrophy, and the second at Boston Children's Hospital in Louis Kunkel's lab studying heme oxygenase and PDE inhibitors as therapeutic strategies for Duchenne muscular dystrophy.
Marshall holds a Ph.D. in molecular, cellular, and integrative physiology and a B.S. in biology, both earned at UCLA.
Contact Jamie Marshall via email at email@example.com.